ClinicalTrials.Veeva

Menu

Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia

T

Tongji Hospital

Status

Withdrawn

Conditions

COVID-19
Endotracheal Intubation

Treatments

Other: severe covid-19 pneumonia with ET

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To analyze the intubation with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, and summarizes the experience of how to avoid the infection of anesthesiologist and ensure the safety of patients with severe covid-19 pneumonia.

Full description

To analyze the intubation time, intubation condition, intubation process, intubation times and success rate of patients with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, the degree of respiratory improvement and survival rate of patients, and summarizes the experience of how to avoid the infection of anesthesiologist and ensure the safety of patients with severe covid-19 pneumonia.

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Wuhan residents;
  • novel coronavirus pneumonia was found to be characterized by fever and cough. Laboratory tests revealed leukocyte or lymphocyte decrease, chest CT examination showed viral pneumonia changes, and was diagnosed as COVID-19 pneumonia according to the national health and Health Committee's new coronavirus pneumonia diagnosis and treatment plan (trial version fifth Revision).
  • Severe and critical patients with covid-19 pneumonia in urgent need of tracheal intubation;
  • Sign informed consent.

Exclusion criteria

  • Suspected patients with covid-19 pneumonia;
  • Patients who need emergency endotracheal intubation due to other causes of respiratory failure;
  • The family refused to sign the informed consent.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems